Publications
Filters
Publications
44 Publications listed
Efficacy of anti-VEGF single-chain variable fragment AAV-based gene therapy in a laser-induced choroidal neovascularisation mouse model
Published 2026
Eye
Nuffield Department of Clinical Neuroscience, University of Oxford,
University of Southampton,
Queen's University Belfast,
Intas Pharmaceuticals Ltd,
Oxford Eye Hospital
10.1016/j.omta.2026.201756
Salman A, Griffiths H, Garba K, Lynn SA, Cree AJ, Szczepan M, Jashal CB, Chozhavel T M R, Rao P, Modi K, MacLaren RE, Yuen HM, Lotery AJ. Mol Ther Adv. 2026 May 9;34(2):201756. doi: 10.1016/j.omta.2026.201756. PMID: 42254804; PMCID: PMC13234463.
Genetic or pharmacological disruption of the MSH3 Y245/K246 IDL binding pocket slows CAG repeat expansion
Published 2026
Huntington's disease (HD)
Brain
University College London (UCL)
10.1093/narmme/ugag031
Goold R, Donaldson J, Gidney F, Goff P, Hamilton J, Elmasri M, Coupland L, Flower M, Tabrizi SJ., NAR Mol Med. 2026 Jun 5;3(2):ugag031. doi: 10.1093/narmme/ugag031. PMID: 42317610; PMCID: PMC13273312.
Health economic evaluations of genomic newborn screening: Approaches by studies within the international consortium on newborn sequencing
Published 2026
Health Economics,
Brain,
Blood,
Genomics,
Eye,
Delivery
Harvard Pilgrim Health Care Institute,
Queen Mary University of London,
Harvard Medical School,
University of Liège,
University of Adelaide,
FHU TRANSLAD, CHU Dijon Bourgogne,
Murdoch Children’s Research Institute,
University of Melbourne,
University of Oxford
10.1038/s41431-026-02136-4
Smith HS, Vu M, Dangouloff T, Schubert C, et al, Eur J Hum Genet. 2026 Jun 4. doi: 10.1038/s41431-026-02136-4. Epub ahead of print. PMID: 42236918
The cost and cost-effectiveness of whole-exome and whole-genome sequencing: a systematic literature review
Published 2026
Genomics
University of Oxford,
Queen Mary University of London
10.1038/s41431-026-02146-2
McElwee F, Sansom SL, Buchanan J, Taylor JC, Wordsworth S., Eur J Hum Genet. 2026 Jun 1. doi: 10.1038/s41431-026-02146-2. Epub ahead of print. PMID: 42225956.
Targeting toxic HTT1a could be the key to treating Huntington's disease
Published 2026
Huntington's disease (HD)
Brain
University College London (UCL)
10.1038/s41582-026-01222-x
Sadler F, Tabrizi SJ. Targeting toxic HTT1a could be the key to treating Huntington disease. Nat Rev Neurol. 2026 Sep;22(9):547-548. doi: 10.1038/s41582-026-01222-x. PMID: 42191933.